About us

Gate Bioscience

Founded in 2021, Gate Bioscience is creating a new class of small molecule therapeutics: Molecular Gates. We are led and advised by a team of world-class drug developers and entrepreneurs, and we are backed by leading venture investors.

Leadership Team

Chief Executive Officer
VP of Discovery Sciences
Scientific Co-Founder
Chief Technology Officer
Chief Scientific Officer
Director, Preclinical Translation
Director, Platform Sciences

Board of Directors

Managing Director, Versant Ventures
General Partner, a16z
Chairman of the Board

Scientific & Strategic Advisors

Board Observer (GV)
Board Observer (ARCH)
Chief Scientific Advisor
Assistant Professor of Biological Engineering, Caltech
Freeman Hrabowski Scholar, HHMI
Group Leader, MRC Laboratory of Molecular Biology
Research Director, Institute of Biotechnology, University of Helsinki

Our Investors